Aggresome formation and pharmacogenetics: Sulfotransferase 1A3 as a model system

Biochemical and Biophysical Research Communications

Volumn 325, Issue 2, 2004, Pages 426-433

  Wang, Liewei ^a   Yee, Vivien C ^b   Weinshilboum, Richard M ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aggresome formation; Pharmacogenetics; Sulfotransferase; SULT1A3

Indexed keywords

ALLOENZYME; SULFOTRANSFERASE 1A3; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME MECHANISM; ENZYME STRUCTURE; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETIC VARIABILITY; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SUBSTITUTION; ANIMALS; ASPARAGINE; CERCOPITHECUS AETHIOPS; COS CELLS; CRYSTALLOGRAPHY, X-RAY; CYSTEINE PROTEINASE INHIBITORS; HUMANS; INCLUSION BODIES; ISOENZYMES; LEUPEPTINS; MODELS, MOLECULAR; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CONFORMATION; RABBITS; RECOMBINANT PROTEINS; RETICULOCYTES; SULFOTRANSFERASES; TRYPTOPHAN; UBIQUITINS;

ORYCTOLAGUS CUNICULUS;

EID: 7644241595     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.10.040     Document Type: Article

References (33)

1. O.E. Salavaggione, M. Wiepert, and R.M. Weinshilboum Thiopurine S-methyltransferase (TPMT) pharmacogenetics: variant allele functional genomics Clin. Pharmacol. Ther. 75 2004 P19
2. R. Weinshilboum, and L. Wang Pharmacogenetics: inherited variation in amino acid sequence and altered protein quantity Clin. Pharmacol. Ther. 75 2004 253 258
3. R. Weinshilboum, and D. Otterness Sulfotransferase Enzymes 1994 Springer-Verlag Berlin, Heidelberg
4. C.N. Falany Enzymology of human cytosolic sulfotransferases FASEB J. 11 1997 206 216
5. M.W.H. Coughtrie Sulfation through the looking glass-recent advances in sulfotransferase research for the curious Pharmacogenomics J. 2 2002 297 308
6. B.A. Thomae, O.F. Rifki, M.A. Theobald, B.W. Eckloff, E.D. Wieben, and R.M. Weinshilboum Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: common functional genetic polymorphism J. Neurochem. 87 2003 809 819
7. C. Szumlanski, D. Otterness, C. Her, D. Lee, B. Brandriff, D. Kelsell, N. Spurr, L. Lennard, E. Wieben, and R. Weinshilboum Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism DNA Cell Biol. 15 1996 17 30
8. L. Wang, W. Sullivan, D. Toft, and R. Weinshilboum Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradation Pharmacogenetics 13 2003 555 564
9. H.-L. Tai, M.Y. Fessing, E.J. Bonten, Y. Yanishevsky, A. d'Azzo, E.Y. Krynetski, and W.E. Evans Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C Pharmacogenetics 9 1999 641 650
10. C. Gordon The intracellular localization of the proteasome Curr. Top. Microbiol. Immunol. 268 2002 175 184
11. R. Garcia-Mata, Y.S. Gao, and E. Sztul Hassles with taking out the garbage: aggrevating aggresomes Traffic 3 2002 388 396
12. R.R. Kopita Aggresomes, inclusion bodies and protein aggregation Trends Cell Biol. 10 2000 524 530
13. R. Garcia-Mata, Z. Bebok, E.J. Sorscher, and E.S. Sztul Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera J. Cell Biol. 146 1999 1239 1254
14. J.A. Johnston, C.L. Ward, and R.R. Kopito Aggresomes: a cellular response to misfolded proteins J. Cell Biol. 143 1998 1883 1898
15. E. Junn, S.S. Lee, U.T. Suhr, and M.M. Mouradian Parkin accumulation in aggresome due to proteasome impairment J. Biol. Chem. 277 2002 47870 47877
16. K.S.P. McNaught, P. Shashidharan, D.P. Perl, P. Jenner, and C.W. Olanow Aggresome-related biogenesis of Lewy bodies Eur. J. Neurosci. 16 2002 2136 2148
17. C. Stumptner, A. Fuchsbichler, H. Heid, K. Zatloukal, and H. Denk Mallory body-a disease-associated type of sequestosome Hepatology 35 2002 1053 1062
18. L.M. Bidwell, M.E. McManus, A. Gaedigk, Y. Kakuta, M. Negishi, L. Pedersen, and J.L. Martin Crystal structure of human catecholamine sulfotransferase J. Mol. Biol. 293 1999 521 530
19. R. Dajani, A. Cleasby, M. Neu, A.J. Wonacott, H. Jhoti, A.M. Hood, S. Modi, A. Hersey, J. Taskinen, and R.M. Cooke X-ray crystal structure of human dopamine sulfotransferase, SULT1A3: molecular modeling J. Biol. Chem. 274 1999 37862 37868
20. S.N. Ho, H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease Site-directed mutagenesis by overlap extension using the polymerase chain reaction Gene 77 1989 51 59
21. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding Anal. Biochem. 72 1976 154 248
22. A. Foldes, and J.L. Meek Rat brain phenolsulfotransferase partial purification and some properties Biochim. Biophys. Acta 327 1973 274 365
23. R.J. Anderson, and R.M. Weinshilboum Phenolsulphotransferase in human tissue: radiochemical enzymatic assay and biochemical properties Clin. Chim. Acta 103 1980 79 90
24. R.L. Barent, S.C. Nair, D.C. Carr, Y. Ruan, R.A. Rimerman, J. Fulton, Y. Zhang, and D.F. Smith Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes Mol. Endocrinol. 12 1998 342 354
25. D.F. Smith, W.P. Sullivan, T.N. Marion, K. Zaitsu, B. Madden, D.J. McCormick, and D.O. Toft Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70 Mol. Cell. Biol. 13 1993 869 876
26. B.A. Thomae, B.W. Eckloff, R.R. Freimuth, E.D. Wieben, and R.M. Weinshilboum Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies Pharmacogenom. J. 2 2002 48 56
27. A.A. Adjei, B.A. Thomae, J.L. Prondzinski, B.W. Eckloff, E.D. Wieben, and R.M. Weinshilboum Human estrogen sulfotransferase (SULT1E1) pharmacogenetics: gene resequencing and functional genomics Br. J. Pharmacol. 139 2003 1373 1382
28. S. Wickner, M.R. Maurizi, and S. Gottesman Posttranslational quality control: folding, refolding and degrading proteins Science 286 1999 1888 1893
29. W.C. Wigley, R.P. Fabunmi, M.G. Lee, C.R. Marino, S. Muallem, G.N. DeMartino, and P.J. Thomas Dynamic association of proteasomal machinery with the centrosome J. Cell Biol. 145 1999 481 490
30. H.J. Lee, and S.J. Lee Characterization of cytoplasmic alpha-synuclein aggregates: fibril formation is tightly linked to the inclusion forming process in cells J. Biol. Chem. 277 2002 48976 48983
31. H. Ito, K. Kamei, I. Iwamoto, Y. Inaguma, D. Nohara, and K. Kato Phosphorylation-induced change of the oligomerization state of alpha B-crystallin J. Biol. Chem. 276 2001 5346 5352
32. A. Ciechanover, and A.L. Schwartz The ubiquitin-proteasome pathway: the complexity and myriad functions of protein death Proc. Natl. Acad. Sci. USA 95 1998 2727 2730
33. E. Junn, S.S. Lee, U.T. Suhr, and M.M. Mouradian Parkin accumulation in aggresomes due to proteasome impairment J. Biol. Chem. 277 2002 27870 27877